Qureight uses cloud-based technology to assist in the structuring of image and paired clinical metadata in complex diseases. By structuring data in this way, it allows for the development of AI-based tools to understand diseases such as lung fibrosis, complex cancers and COVID-19. Moreover, it enables scientists to track disease progression and drug response, developing …

BioLib is a developer of the world’s first platform for zero-knowledge analysis of biological and health data. Dubbing it the “library of biological data science,” the platform enables data holders and analytics experts to collaborate securely and conveniently by giving scientists access to a global marketplace for advanced bioinformatics and diagnostics tools — including access …

CancerAppy has developed a platform based on Big Data and AI, specialized in the field of cancer research, developed by and for scientists and drug developers that fills the gap between basic data tools and pharma intelligence tools. Said platform is meant to efficiently and effectively de-risk the process of cancer drug discovery and development …

University of Cambridge technology spin-out Zetta Genomics is a leader in large-scale genomic data management for precision medicine. It is employing big data technology and best practice security to leverage genomic data benefits while preserving data privacy. The company’s flagship offering, the XetaBase platform, is a genomic data management technology that powers the discovery and …